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SUMMARY
Lactate produced by muscle during high-intensity activity is an important end product of glycolysis
that supports whole body metabolism. The lactate shuttle model suggested that lactate produced
by glycolytic muscle fibers is utilized by oxidative fibers. MCT4 is a proton coupled monocarboxylate
transporter preferentially expressed in glycolytic muscle fibers and facilitates the lactate efflux. Here
we investigated the exercise capacity of mice with disrupted lactate shuttle due to global deletion of
MCT4 (MCT4/) or muscle-specific deletion of the accessory protein Basigin (iMSBsg/). Although
MCT4/ and iMSBsg/ mice have normal muscle morphology and contractility, only MCT4/
mice exhibit an exercise intolerant phenotype. In vivo measurements of compound muscle action po-
tentials showed a decrement in the evoked response in theMCT4/mice. This was accompanied by a
significant structural degeneration of the neuromuscular junctions (NMJs). We propose that disrup-
tion of the lactate shuttle impacts motor function and destabilizes the motor unit.
INTRODUCTION
A hallmark of high-intensity exercise is the increased production of lactate by muscles, which is coupled
with an increase in lactate in circulation. Lactate was once considered a waste product of anaerobic glycol-
ysis and the cause of muscle fatigue and decreased force generation (Hill et al., 1924). In the late 1980s,
George Brooks (Brooks, 1986) proposed that lactate produced by fast-twitch muscle fibers through both
aerobic and anaerobic glycolysis (Connett et al., 1990) is shuttled to oxidative fibers and to other organs
via circulation, to fuel oxidative metabolism during exercise.
Lactate is transported across the plasma membrane bymonocarboxylate transporters (MCTs), encoded by
the SLC16A gene family (Adijanto and Philp, 2012). MCT1 (SLC16A1) and MCT4 (SLC16A3) are H+-coupled
lactate transporters found in the sarcolemma of skeletal muscle (Bonen, 2001; Wilson et al., 1998). MCT1
has higher affinity for lactate (Poole and Halestrap, 1993) and is predominantly expressed in slow-twitch
muscle fibers, where it facilitates the influx of lactate. MCT4 has lower affinity but higher capacity for lactate
transport (Dimmer et al., 2000) and is expressed in fast twitch where it mediates lactate efflux. The direction
of the flux is primarily controlled by the gradient of lactate and protons (Juel, 1997). To be trafficked to the
plasma membrane, MCT1 and MCT4 need to assemble in the ER with an accessory protein called Basigin
(Bsg or CD147) (Kirk et al., 2000), a member of the immunoglobulin superfamily. In Bsg knockout mice,
MCTs are not trafficked to the plasma membrane but are targeted for degradation (Philp et al., 2003).
The model of the lactate shuttle as a mechanism to distribute high-energy metabolites between glycolytic
and oxidative cells has been applied beyond skeletal muscle and exercise. It has been suggested that
lactate is shuttled between astrocytes and neurons during neuronal stimulation (Pellerin et al., 1998). In
the brain, it is not yet clear if the direction of the lactate shuttle is from astrocytes to neurons or vice versa.
Multiple studies have tried to address the question, but the results are still inconclusive as discordant find-
ings have been published (Dı́az-Garcı́a et al., 2017; Mangia et al., 2009).
In this study, we have examined the contribution of the lactate shuttle to exercise capacity of mice using a
global Slc16a3 knockout (MCT4/) and an inducible muscle specific Bsg knockout mouse (iMSBsg/)
models. We performed in vivo and ex vivo analyses of exercise capacity, neuromuscular function, and
morphometry in these mouse models. Surprisingly, our results revealed that disruption of lactate transport
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decreased exercise performance without altering muscle structure/function and was accompanied by a
progressive structural and functional impairment of the neuronal component of the motor unit.
RESULTS
MCT4/ Mice Develop Exercise Intolerance
MCT4/ mice were purchased from Taconic Biosciences. The animals were born at normal Mendelian ra-
tio, with no apparent defects at birth. There were no developmental delays noted in MCT4/ mice, as
confirmed by normal growth curves and comparable body (Figure 1A) and muscle (Figure 1B) weights be-
tween MCT4+/+ and MCT4/ mice.
MCT4 was previously shown to be expressed in fast-twitch muscle fibers (Bonen, 2001). In agreement with
this we found by western blot analysis of muscle lysates from MCT4+/+ mice that MCT4 was mainly ex-
pressed by glycolytic fast-twitch (EDL, TA, and quadriceps) and mixed (gastrocnemius) muscles. MCT4
was completely absent in muscles lysates prepared from MCT4/ mice (Figure 1C). MCT1, on the other
hand, was expressed in all muscle types, but at higher levels in oxidative slow-twitch muscles including so-
leus, diaphragm, and heart (Figure 1C). We performed immunofluorescent labeling on frozen sections of
the extensor digitorum longus (EDL) and found MCT4 was localized at the sarcolemma in all the fibers
of MCT4+/+ EDL muscles, where it co-localized with wheat germ agglutinin (WGA). No MCT4 labeling
was detected in frozen sections of EDLs from MCT4/ mice (Figure 1D). Because the MCTs are bidirec-
tional and can function for influx or efflux of lactate, we examined whether MCT1 expression was increased
in the EDL for compensation. MCT1 immunofluorescence on EDLs cryosections showed that the trans-
porter has a similar expression pattern from both MCT4+/+ and MCT4/ mice, where it was preferentially
expressed in oxidative fiber (smaller sized) (Figure 1D). Immunofluorescence labeling of EDL cross sections
labeled with antibodies detecting MCT1, type IIa MyHC (oxidative fibers), and type IIb MyHC (glycolytic
fibers) confirmed that the transporter is primarily expressed in IIa and IIx (identified as non-positive for
either IIa or IIb MyHC) fibers (Figure 1E).
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Figure 1. MCT4/ Mice Have Normal Development
(A and B) (A) Weight gain over 40 weeks of age and (B) muscle weight at 3 months of age in MCT4+/+ and MCT4/ mice
(n = 15 per group). Values are mean and SEM.
(C) Western blot analysis of MCT4 and MCT1 expression in skeletal muscle and cardiac muscle. EDL, extensor digitorum
longus; TA, tibialis anterior; Sol, soleus; Quad, quadricep; Gastr, gastrocnemius; Diaph, diaphragm.
(D) Representative immunostaining of EDL frozen sections fromMCT4/ and MCT4+/+ mice labeled with WGA (left, red)
and antibodies against MCT4 (middle, green) and MCT1 (right, green).
(E) Representative immunolabeling of EDL frozen sections with MCT1 (blue) and antibodies against type IIb (red) and IIa
(green) fibers. Scale bar, 50 mm.
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To investigate whether alterations of lactate transport in MCT4/ mice could affect normal exercise per-
formance, we tested MCT4/ and MCT4+/+ mice with voluntary wheel running and forced endurance
treadmill. Voluntary wheel activity was comparable between the two groups at 3 months of age but was
reduced by 2.5-fold in 12-month-old MCT4/ mice (Figure 2A).
The endurance treadmill protocol was designed to gradually increase the running speed over time, up to
26 m/min, a speed at which oxygen consumption in C57BL/6 mice reaches approximately 80% of VO2max
(high-intensity exercise) (Desai and Bernstein, 2001) (Figure 2B). At high-intensity, most of the energy to
support muscle activity is derived from carbohydrates, resulting in the production and release of lactate
from muscle fibers and the consequent increase in blood lactate. Consistently, blood glucose decreased
by 30% after treadmill (Figure S2). Treadmill performance declined with age in both genotypes and,
consistent with the wheel running results, MCT4/ mice ran less compared with controls (Figure 2C).
MCT4/ mice could reach the maximum speed but, unlike MCT4+/+, could not endure the high-intensity
performance, as indicated by the quicker accumulation of electric shocks over time (Figure 2D). This sug-
gests that, indeed, lack of MCT4 and disruption of muscle lactate efflux cause an age-dependent and ex-
ercise-intensity-dependent impairment of exercise capacity.
Lack of MCT4 Does Not Affect the Intrinsic Properties of the EDL Muscle
To determine if the exercise intolerance was due to structural alterations of MCT4/muscle fibers, we per-
formed a histological analysis of EDL cross sections, looking for signs of degeneration, fibrosis, or fiber type
switch. We focused on EDL muscles for a variety of reasons: first, EDL is highly engaged during locomotion
in rodents; second, it expresses high levels of MCT4 and its fiber type composition is primarily fast; and
finally, it can be easily and consistently dissected for functional studies.
H&E staining showed normal fiber morphology with no signs of immune infiltrates, fibrotic tissue, or central
nucleation (Figure 3A). Consistent with the normal muscle mass (Figure 1B), fiber size measured as mini-
mum Feret diameter was comparable between genotypes both at 3 and 12 months of age (Figures 3B
and 3C).
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Figure 2. MCT4/ Are Exercise Intolerant
(A) Voluntary wheel running, cumulative number of revolutions over 60 h of MCT4/ and MCT4+/+ mice, at 3 and
12 months of age (n = 3 each group, One way-ANOVA test, ****p < 0.0001).
(B) Treadmill protocol for endurance test at 5 incline.
(C) Total distance reached in the endurance treadmill test by MCT4+/+ and MCT4/ mice at 3, 6, and 18 months of age
(n = 10 MCT4+/+ and 23 MCT4/ at 3 months, n = 10 MCT4+/+ and 15 MCT4/ at 6 months, n = 7 MCT4+/+ and 8
MCT4/ at 18 months, three independent groups. Student t test, *p < 0.05, **p < 0.001).
(D) Representative traces of cumulative number of shocks over time during treadmill test of MCT4/ and MCT4+/+ mice
at 6 months of age. All the data are rapresented as mean and SEM.
See also Figure S1.
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Changes in muscle metabolism are often correlated with changes in the proportion of glycolytic and oxida-
tive fibers. To address this possibility, we immunolabeled EDL frozen sections with antibodies against the
myosin heavy chain (MHC) isoforms (Figure 3D). The relative abundance of each fiber type was similar be-
tween genotypes at 3 and 12 months of age (Figures 3E and 3F).
To determine if the exercise intolerance in MCT4/ mice could be caused by defects in muscle contrac-
tility, we performed an ex vivo assessment of strength and fatigability in isolated EDL muscles using field
depolarization. This technique bypasses the neuronal and neuromuscular junction (NMJ) components and
focuses specifically on measuring the contractile and metabolic properties of the muscle. Isometric twitch
and tetanic forces, both absolute (Table S1) and after normalization by cross-sectional area (CSA) (Figures
4A and 4B), were not different between MCT4/ and MCT4+/+. Similar optimal length (L0), mass, and CSA
were consistent with the tissue weight measurements (Figure 1B) and the histomorphometric analyses (Fig-
ures 3A–3C). EDL muscles from MCT4+/+ and MCT4/ mice had similar fatigability profiles (Figure 4C), as
determined by administering repeating submaximal tetanic contractions every second for 8 min. The same
trend was found in younger (3 months old) and older (18 months old) mice (data not shown). This was
despite significant differences in the accumulation of intramuscular lactate, which was higher (50%) in
MCT4/ stimulated muscles compared with the unstimulated andMCT4+/+ conditions (Figure 4D). There-
fore, intramuscular accumulation of lactate due to lack of MCT4 did not have an effect on muscle contrac-
tility. Because MCT4 is a proton-linked lactate transporter and contributes to the control of the intracellular
pH, we tested whether other pH modulators like carbonic anhydrases 2, 3, and 4 (Car2, Car3, Car4) or pro-
ton exchangers such asMct1 and Na+/H+ exchanger (Nhe1) were overexpressed in the MCT4/muscle as
a compensatory response. qPCR analysis of TAmuscles from 6-month-oldmice showed no difference in the
expression of these genes (Figure 4E). Together, these data suggest that lactate accumulation in muscle
does not alter muscle contractility or fatigability and therefore is not themain cause of the reduced exercise
capacity of MCT4/ mice.
iMSBsg/ Mice Have Normal Exercise Capacity
To strengthen our finding and further investigate whether deletion of MCT4 in muscle could have any effect
on exercise capacity, we generated mice with a skeletal muscle-specific deletion of Basigin (BSG). BSG is
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Figure 3. Skeletal Muscle Histology Is Not Affected by the Lack of MCT4
(A) Representative H&E staining of EDL cryosections from MCT4+/+ and MCT4/ mice; scale bar, 50 mm.
(B and C) Frequency histograms of fiber size of EDLs measured as minimum Feret diameter fromMCT4+/+ andMCT4/ at (B) 3 and (C) 12 months (n = 5 each
group, counting all the fibers in the entire muscle section).
(D) Representative immunolabeling of MCT4+/+ and MCT4/ EDL sections with antibodies against type IIB and IIa fibers and laminin for sarcolemma.
(E and F) Percentage of IIb and IIa fiber types in EDLs from MCT4+/+ and MCT4/ at (E) 3 and (F) 12 months of age (n = 5 each group, two-way ANOVA test).
All the data are rapresented as mean and SEM.
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the accessory protein required for maturation and trafficking of both MCT1 and MCT4 to the sarcolemma.
When Bsg is knocked out, MCT1 and MCT4 fail to traffic to the plasma membrane and are targeted for
degradation. Specific deletion of Bsg in skeletal muscle was achieved by crossing BsgFlox/Flox mice with
the tamoxifen-inducible skeletal muscle-specific cre recombinase mice, Acta1-cre mice. The cre recombi-
nases was induced when the mice reached 12 weeks of age to avoid possible developmental effects of the
lack of BSG. Western blot analysis confirmed that Bsg was ablated from skeletal muscle of iMSBsg/mice
and that the cre-recombinase driven by Acta1 was not active in the cardiac muscle (Figure 5A). BSG, MCT1,
and MCT4 were undetectable in lysates prepared from skeletal but not cardiac muscle.
Since tamoxifen can acutely affect cardiac muscle contractility (Asp et al., 2013), after the induction of the
cre recombinase, we waited 3 weeks for the tamoxifen to be completely cleared from the system before
testing the animals for exercise capacity. Using the forced treadmill test, we found that there was no sig-
nificant difference in the total distance run by the iMSBsg/ mice compared with controls (Figure 5B).
We then tested whether the complete disruption of the lactate shuttle had an effect on the contractile
properties of the muscles by performing ex vivo measurements of force and fatigability in isolated EDLs.
As for the MCT4/ muscles, we did not detect any difference in maximal isometric force (Figures 5C
and 5D) and fatigability (Figure 5E) between iMSBsg/ and control mice. Since the MCT4/ presented
a decrease in exercise capacity already at 3 months and we did not observe any difference between con-
trols and iMBsg/, we did not investigate the performance of these animals at older ages. Overall, the
studies on iMSBsg/ mice confirmed that the absence of MCT1 and MCT4 in the sarcolemma of skeletal
muscle does not affect exercise capacity and muscle ex vivo contractile properties.
Loss of MCT4 Leads to Degeneration of the NMJ and Decreased Compound Muscle Action
Potential Amplitude
In many neuropathies (Hill, 2003), e.g., Charcot-Marie-Tooth disease (CMT) and Amyotrophic Lateral Scle-
rosis (ALS), a progressive decline in muscle strength and exercise capacity is caused by pathologies of the
motoneuron, nerves, and/or the NMJ rather than a primary defect in the muscle. We therefore investigated
whether ablation of MCT4 could impact the structure and function of the motor unit components upstream
of muscle.
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Figure 4. Lack of MCT4 Does Not Impair the Contractile Properties of the Skeletal Muscles
(A and B) (A) EDL twitch and (B) tetanic forces generated ex vivo (n = 4 each group).
(C) EDL fatigue traces (n = 4 each group).
(D) Intramuscular lactate in unstimulated and stimulated gastrocnemius muscles (n = 4 each group, two-way ANOVA test,
interaction: p < 0.01, stimulation: ***p < 0.001, genotype: *p < 0.05).
(E) qPCR analysis of genes involved in pH control in TA muscles of 6-month-old MCT4+/+ and MCT4/ mice
(n = 3 MCT4+/+ and 5 MCT4/). All the data are rapresented as mean and SEM.
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It was previously reported that MCT4 is expressed in astrocytes in the Central Nervous System (CNS),
particularly in the cortex and hippocampus of both rats and mice. qPCR analysis of Mct4 (Slc16a3)
mRNA in spinal cord samples demonstrated the presence of the transcript, although the levels were 100
times lower than in skeletal muscle (Figure 6A). To determine the cellular distribution of MCT4-expressing
cells in the spinal cord, we performed fluorescence in situ hybridization (FISH) on frozen sections from the
lumbar spinal cord of MCT4+/+ mice and co-labeled with nuclear staining and GFAP (Glial fibrillary acidic
protein), a marker for glial cells. The in situ hybridization showed widespread expression ofMct4 in both the
gray and white matter (Figure 6B). Since we detectedMct4 expression in the spinal cord, we sought to test
whether the lack of MCT4 affected the motor unit, beginning with the motoneuron. We used cresyl violet
staining in lumbar spinal cord cryosections to detect the Nissl substance in neurons (Figure 6C). We did not
detect any difference in the spinal cord histomorphological features between genotypes, with normal
boundaries between white and gray matter. Motor neurons were identified as Nissl-positive cells with a
clearly visible nucleus and a soma larger than 100 mm and were counted in three separate sections of
the lumbar spinal cord. The number of motoneurons was not different between MCT4/ and MCT4+/+
(Figure 6D), suggesting that lack of MCT4 does not induce neuronal cell death.
We then performed a morphometric analysis of the sciatic nerve of 6-month-old MCT4+/+ and MCT4/ mice
(Figure 6E) to determine if the lack of MCT4 altered the number, size, and/or myelination of axons. Toluidine
blue staining of semithin sciatic nerve sections revealed no differences in the density of myelinated axons; how-
ever, we found a small but significant increase in axons diameters in MCT4/ samples, driven by the increased
occurrenceof large axons (Figure 6F). Theg-ratio (ameasureofmyelin thickness)was similar betweengenotypes.
The synapse between the motoneurons and the skeletal muscle is called neuromuscular junction (NMJ).
Alterations in the NMJ are associated with poor motor performance and exercise intolerance. We then
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Figure 5. iMSBsg/ Mice Do Not Show Exercise Intolerance
(A) Representative western blot analysis of BSG, MCT1, and MCT4 in skeletal muscles and cardiac muscle of iMSBsg/
and iMSBsg+/+ mice after tamoxifen or vehicle treatment.
(B) Total distance reached during the treadmill test by iMSBsg/ and iMSBsg+/+ at 6 months of age (n = 5 each group).
Ex vivo EDL (C) twitch force, (D) tetanic force, and (E) fatigue traces (n = 3 each group). All the data are rapresented as
mean and SEM.
See also Figure S2
512 iScience 22, 507–518, December 20, 2019
sought to understand if the lack of MCT4 affects the integrity of the NMJ. We assessed the morphology of
the NMJ in EDL and soleus muscles by performing whole-mount immunolabeling of the pre-synaptic axons
(SMI32 ab) and vesicles (SV2), as well as of the post-synaptic nicotinic acetylcholine receptors (alpha-bun-
garotoxin) (Figure 7A). Although we did not detect any significant difference in NMJ morphology in
Figure 6. Lack of MCT4 Does Not Affect the Morphology of Motoneurons
(A) mRNA expression of Mct4 in spinal cord and skeletal muscle. Values are normalized to Rplp0 housekeeping gene.
(B) In situ hybridization ofMct4mRNA (red) in lumbar spinal cord cryosections (10 mm thickness). Sections were co-labeled
with nuclear DAPI staining (blue) and an antibody against GFAP (green). Scale bar, 200 mm; insert scale bar, 50 mm.
(C) Representative cresyl violet staining of lumbar spinal cord cryosections. Arrowheads in the enlarged insert indicate
motoneurons in the ventral horn. Scale bar, 400 mm; insert scale bar, 200 mm.
(D) Quantification of the number of motoneurons in lumbar spinal cord sections (25mm) of MCT4+/+ and MCT4/ mice
(n = 3 animals each group, three sections per animal evaluated).
(E) Examples of toluidine blue staining of semithin sections of sciatic nerves (0.5 mm thickness). Scale bar, 200 mm.
(F) Morphometric analysis of axon diameter and g-ratio in MCT4/ and MCT4+/+ sciatic nerves (n = 3 each group, entire
section was counted). *p < 0.05. All the data are rapresented as mean and SEM.
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muscles from 6-month-old mice, the incidence of disrupted NMJs in EDL of 12-month-old MCT4/ mice
was significantly higher (p < 0.0001, Chi-square test), with signs of denervation and re-innervation (Fig-
ure 7A). In 12-month-old MCT4+/+ muscles, only a minimum number of NMJs showed signs of partial
denervation. Among the NMJs analyzed in MCT4/ mice, 15% were partially or total denervated and
8% had terminal sprouting (Figures 7A and 7B). The analysis of NMJs in the soleus muscles showed no dif-
ference between MCT4/ and MCT4+/+ mice (Figure S3A), suggesting that the effects of MCT4 ablation
are more evident in fast motor units. Analysis of the density of the acetylcholine receptors (AChRs) at the
Figure 7. NMJ Morphology and CMAPs Are Impaired in MCT4/ Mice
(A) Representative images of whole-mount immunohistochemistry of EDL muscles labeling motor axons (SMI32, green),
pre-synaptic nerve terminals (SV2, green) and post-synaptic endplate (rhodamine-conjugated a-bungarotoxin, red). I.,
intact; P.D., partially denervated; F.D., fully denervated; M.I., multiple innervated.
(B) Quantification of intact and disrupted NMJs in EDLs of 12-month-old MCT4/ and MCT4+/+ (n = 3 each group,
Chi-square, p < 0.0001).
(C) Representative CMAP trace showing the electromyographic signal recorded from gastrocnemius muscle (black trace)
upon stimulation of the sciatic nerve (green trace). Amplitude and RMS are indicated.
(D) CMAPs RMS (Root-Mean-Square) recorded at 20 Hz in 6-month-old MCT4/ and MCT4+/+ mice (n = 4 each group,
Student t test, *p < 0.05). All the data are rapresented as mean and SEM.
See also Figure S3
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post-synaptic endplates showed a similar result, with an increase in the fragmentation of the NMJs of the
12-month-old MCT4/ mice compared with the MCT4+/+ (Figures S3B and S3C). No difference in the
integrity of the NMJs was detected in the 6-month-old mice.
To assess the functional activity of the motor unit, we performed in vivo compound muscle action potential
(CMAP) studies on 6-month-old MCT4+/+ and MCT4/ mice. We applied repeated sciatic nerve stimula-
tions with increasing frequencies and recorded the evoked electromyographic (EMG) signal in the gastroc-
nemius muscle (Figure 7C). No difference was found in the amplitude decrement after 30 s of repetitive
stimulations (data not shown). CMAP amplitude, however, expressed as root mean squared (RMS), was
significantly lower in MCT4/ at all frequencies tested (Figure 7D). Interestingly, loss of NMJ integrity
and decreased CMAP amplitude have been described in patients with CMT (Elbracht et al., 2014) (Spauld-
ing et al., 2016) (Cipriani et al., 2018). Together, these data suggest that ablation of MCT4 had a negative
effect on the structural and functional stability of the motor unit.
DISCUSSION
In the current study, we investigated whether disruption of the lactate shuttle had an effect on exercise ca-
pacity, by characterizing the phenotype of the MCT4/ mouse. The results of our study showed that mice
with a global knockout of MCT4 had defects in locomotion both when tested for spontaneous in-cage ac-
tivity (wheel running) and forced treadmill exercise (Figure 2). The decrement in motor function was more
evident in the spontaneous activity after the mice reached the adult age, suggesting that the phenotype is
progressive, and exacerbated during forced endurance test (Figure 2C). By combining the results from the
MCT4/mice with those obtained from the iMSBsg/, we can conclude that the deletion of lactate trans-
porters from the skeletal muscles is not detrimental for the muscle itself. Instead, the exercise intolerance
observed is accompanied by a functional and structural impairment of the neuronal component of the mo-
tor unit. Although we cannot exclude that lack of MCT4 in the CNS affects behavior, the integration of
in vivo and ex vivo functional assessments with morphological analyses suggests that a motor neurons
and NMJs are mostly affected.
For decades, lactate was considered the cause of fatigue in exercising muscles based on experiments con-
ducted in the 1920s on non-oxygenated frog muscles (Hill et al., 1924). The lactate shuttle hypothesis was
described over 30 years ago by Brooks (Brooks, 1986), who suggested that lactate is a substrate exchanged
between glycolytic and oxidative tissues/cells, allowing for the control of its cytosolic concentration. During
the past 20 years, researchers in the muscle and exercise physiology fields have worked to understand the
real effects of lactate and H+ during muscle activity (Allen et al., 2008; Azevedo et al., 2007). It has now been
established that lactate is not cause of fatigue (Posterino et al., 2001). The fate of the H+ ions, which are co-
transported together with lactate during fatiguing muscle contraction (Kemp et al., 2006; Robergs et al.,
2004; Robergs, 2017), however, is still not clear. In our study we showed that in ex vivo electrically stimulated
MCT4/ muscles, despite a 2-fold accumulation of intramuscular lactate, there was no decrement in force
generation or fatigability (Figure 4), supporting the fact that increased lactate was not the cause of fatigue.
We also tested whether addition of exogenous L-lactate in the bath during the fatigue test could alter mus-
cle performance, but no difference was detected (data not shown).
We used Bsg floxed mice to indirectly knock out both transporters in adult muscle, with the goal of testing
whether it would have a detrimental impact on exercise capacity. Mice ubiquitously lacking Bsg are re-
ported to be sterile and with memory and learning deficits (Naruhashi et al., 1997), but their exercise capac-
ity has not been investigated. To our surprise, there was no difference between controls and iMSBsg/ in
terms of running capacity or ex vivo contractility. This result is in contrast to the lactate shuttle hypothesis
and more recent work, which suggest that lactate derived from skeletal muscle is a key metabolite utilized
by different tissues as energy substrate (Hui et al., 2017). We cannot exclude that the lack of both trans-
porters and their binding partner, BSG, may have caused a metabolic reprogramming in the skeletal mus-
cle to limit lactate production and utilization. Taken together, the results from the two mouse models show
that the systemic redistribution of muscle-derived lactate, operated by MCT1 and MCT4, can be bypassed
during exercise.
Since its conception, the lactate shuttle theory has been applied to other systems such as cancer and neu-
roenergetics. Pellerin andMagistretti (Pellerin et al., 1998) presented the astrocytes-neurons lactate shuttle
(ANLS) hypothesis where, in situations of high energy demand, astrocytes are a source of lactate and
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neurons are lactate consumers. Several studies have shown the expression of MCT4 in astrocytes in brain
cortex and hippocampus (Bergersen et al., 2001) (Rafiki et al., 2003). In this study, we investigated the pres-
ence of MCT4 in the spinal cord and the potential role of lactate in supporting motor neuron activity. The in
situ hybridization data (Figure 6B) showed that MCT4 is expressed by multiple cell types, but we did not
confirm the expression in any particular cell type. Based on information available from the Allen Brain Atlas,
as well as the topology of our in situ mRNA staining, we suggest that motoneurons are among the cells
expressing MCT4. This is surprisingly new since previous reports indicated that MCT4 is expressed only
in astrocytes. The neuronal MCT4 expression, in contrast with the ANLS hypothesis, is, however, supported
by several publications suggesting that neurons rely on glycolytic metabolism for energy production, when
stimulated (Gjedde and Marrett, 2001; Simpson et al., 2007) (Mangia et al., 2009) (Dı́az-Garcı́a et al., 2017).
Future investigations will need to address if MCT4 and lactate have roles in the viability of themotor neuron
and whether, as seen in several cancer studies (Marchiq et al., 2015), the blockade of lactate flux induces
senescence and impairs neuronal signaling.
By performing CMAPmeasurements onMCT4/mice, we found a decrement in the amplitude of the EMG
signal upon direct stimulation (Figure 7). Lower CMAP amplitude is a hallmark of axonal neuropathies such
as CMT, multiple sclerosis (MS), and other pathologies of the NMJ. Despite the clear functional decline of
the motor capacity (Figure 2) and the lower CMAPs amplitude in young adult mice, we did not detect any
evident structural change in the sciatic nerve (Figure 6). This is consistent with the normal latency estimated
during our CMAP experiments in both young adult and old mice (Manganelli et al., 2016) (Cornett et al.,
2016).
Structural disruption of NMJs was evident in older mice (Figure 7), when the decline in spontaneous activity
is alsomore pronounced. The results suggested thatMCT4 and lactatemay have an effect on the long-term
integrity of the motor unit and NMJs. It is interesting to note that the degeneration of the NMJs was
observed only in EDL muscles, which express MCT4 at the sarcolemma, and not in soleus muscles, which
express mainly MCT1. Based on our results, we speculate that lactate released by the skeletal muscle may
be necessary for the stability of the NMJs either functioning as metabolic substrate or as signaling mole-
cule. A variety of factors as myokines and neurotrophic factors are important for the structural and func-
tional integrity of the NMJ (Lin et al., 2008, 2001). Indeed, exercise has been shown to induce remodeling
and adaptation of the NMJs (Deschenes et al., 2019), and lack or reduced muscle activity can have a detri-
mental effect on NMJ structure and function as seen during aging (Gonzalez-Freire, 2014).
It has been reported that MCT4 is expressed by Schwann cells of the peripheral nervous system (PNS) (Do-
mènech-Estévez et al., 2015), where it might have a role in the maintenance of axon myelination. In our
model, we did not detect the expression of MCT4 mRNA or protein in the PNS and we also did not observe
any defect in axons myelination (Figure 6).
In conclusion, the results of our study show that the exercise intolerance observed in the MCT4/ mice is
not attributable to disruption of the lactate shuttle between fast-twitch and slow-twitch muscle fibers.
Rather, in the MCT4/mice there is an instability of the motor unit and, in particular, a progressive degen-
eration of the NMJs. We propose that the lack of MCT4 frommotoneurons decreases their activity possibly
by altering the coordinate action of the metabolic pathways responsible for ATP production. This may in
turn affect the release of neurotransmitters at the NMJs, hence the decreased amplitude of the CMAPs re-
corded. Therefore, the decreased overall activity of the MCT4/ mice is associated with instability and
premature degeneration of the NMJs. We suggest that the phenotype of MCT4/ mice is reminiscent
of neurodegenerative diseases such as Charcot-Marie-Tooth, Multiple Sclerosis, or ALS, and therefore it
would be interesting to evaluate the role of MCT4 in these pathologies.
Limitations
In the current study we found that the lack ofMCT4 negatively affects the exercise capacity of themice but it
had no impact on ex vivo muscle physiology. MCT4/ mice did exhibit a decrease in amplitude of the
CMAPs accompanied by structural changes at the levels of the NMJs. Although our data suggest that
the exercise intolerance is due to instability of the motor unit, our approach did not have sufficient resolu-
tion to determine whether the functional impairment of the NMJs is a cause or a consequence of exercise
intolerance. In addition, we could only detect MCT4 transcripts in the spinal cord since the immunostaining
to demonstrate the presence of the protein was not reliable because was giving a high non-specific signal
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also in the MCT4/ samples. We could not ascertain whether these effects resulted from lack of MCT4
expression in the motoneurons or astrocytes. In this study, owing to limited technology, we could not
show whether the lack of MCT4 had a direct effect on neurotransmitter release from the pre-synapses or
impaired activation of the motoneurons. Future studies using motoneurons and/or astrocytes MCT4 con-
ditional knockout mice will help elucidate this important point.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.11.041.
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Figure S1, related to figure 2: Blood glucose measurement before and after
treadmill test: (A) Venus blood glucose measured in 6 months old MCT4+/+ and MCT4-/-
before and after treadmill test, ( n = 5 each group). Error bars = SEM.
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Figure S2, related to figure 5: Generation of the Bsg conditional mice. (A) Design
of targeting vector to produce floxed Bsg mouse with placement of LoxP sites to target
exon 1 of Bsg gene for deletion. (B) Southern blot confirmation of five ES clones (233,
234, 251, 253 and 272) as correctly targeted and used for injection.
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Fig S3, related to figure 7: Morphological analysis of NMJs in soleus muscles and
postsynaptic endplate: (A) Quantification of intact and disrupted NMJs in soleus
muscles of 12 months old MCT4-/- and MCT4+/+ (n = 3 each group). Quantification of the
density of Acetylcholine receptors (AChR) at the postsynaptic endplate from EDLs cross
sections from (B) 6 months old (n = 4 each group, 6 NMJs per animal) and (C)12 months
old (n = 3 each group, 3 NMJs per animal) MCT4+/+ and MCT4-/- mice. Error bars = SEM.
Table S1 related to Figure 4: Contractile and morphometric measurements of EDL muscles. 
MCT4+/+ MCT4-/- P 
EDL contractility N=4 N=5 
Twitch force (mN) 94.68±13.90 118.22±4.71 0.121 
Twitch force (N/cm2) 5.36±0.62 6.04±0.13 0.265 
Tetanic force (mN) 345.08±53.87 447.76±7.18 0.070 
Tetanic force (N/cm2) 19.42±2.10 22.95±0.57 0.115 
Twitch - TTP (ms) 20±0.42 20.10±0.27 0.841 
Twitch - RFD (mN/sec) 12747.25±1909.27 14428.00±892.54 0.419 
Fatigue AUC 956.90±83.52 981.38±82.61 0.843 
EDL morphometry N=4 N=5 
L0 (mm) 11.93±0.37 12.56±0.10 0.106 
Mass (mg) 9.98±0.63 11.74±0.52 0.066 
CSA (mm2) 1.76±0.12 1.96±0.08 0.191 
Values are mean ± SEM. TTP, time to peak; RFD, rate of force development; CSA, cross sectional area; L0, 
muscle length. 
TRANSPARENT METHODS 
Animals. 
All animal procedures were performed in accordance with the Thomas Jefferson University Institutional 
Animal Care and Use Committee. MCT4 (slc16a3) knock out mice, stock no. TF3223A, were obtained 
from Taconic Farms. Mice were backcrossed for 10 generations to C57BL/6NTac to obtain a 99% 
C57BL/6 background. Bsgflox/flox mice were obtained from Dr. Nowak at University of Illinois. The mice 
were generated by inGenious Targeting Laboratory (www. Genetargeting.com). The construct was 
designed to target exon 1 for conditional deletion as shown in the supplementary material (Fig. S1A). 
Briefly, ten micrograms of the targeting vector were linearized by NotI and then transfected by 
electroporation of BA1(C57Bl/6 x 129/SvEv) (Hybrid) embryonic stem cells. After selection with G418 
antibiotic, surviving clones were expanded for PCR analysis and southern blotting to identify 
recombinant ES clones. Sequencing was also performed on purified PCR DNA to confirm the presence 
of the LoxP cassette using the SDL2 primer. Five positive clones were confirmed by southern blotting 
(Fig. S1B) and used for blastocyst injection, implantation and generation of chimeras. Germline 
transmission was confirmed in four of the clones. Bsgflox/flox were crossed with tamoxifen inducible Acta1-
cre/Esr1 mice (Jackson Lab, stock no 025750 HSA-MCM). Induction of the cre-recombinase was 
obtained by daily injection of tamoxifen (2mg/kg), for 5 consecutive days. Bsgflox/flox:Cre+/- mice injected 
with vehicle (15% ethanol in sunflower oil) were used as control. Mice were housed at 22ºC and under 
12:12h light-dark cycle. Male mice were used in all the reported experiments except for the reported 
wheels running test and NMJs morphology data. 
Histology. 
Tibialis anterioris (TA) muscle and extensor digitorum longus (EDL) muscles were frozen in Tissue-Tek 
OCT compound (WVR, Atlanta GA) and stored at -80ºC. 10µm cryosections were cut and used for 
subsequent histological and immunofluorescence stainings. For H&E staining, a standard procedure 
was followed. For fiber typing analysis, sections were stained with monoclonal antibodies against 
myosin heavy chains produced by Dr Schiaffino’s lab at University of Padova and distributed by the 
Developmental Studies Hybridoma Bank (DHSB, University of Iowa). Ba-D5 (supernatant), specific for 
MyHC-1 was used at 1:100 dilution, Bf-F3 (purified antibody), specific for MyHC-IIB was used at 1:100 
and Sc-71 (supernatant), specific for MyHC-IIA, was used at 1:50. The secondary antibodies: donkey 
anti-mouse IgG2b AlexaFluor647 to bind Ba-D5; donkey anti-mouse IgM AlexaFluor 555 to bind Bf-F3 
and donkey anti-mouse IgG1 AlexaFluor 488 to bind Sc-71 (Life Technologies, New York) were diluted 
1:500. Membranes were counterstained with anti-laminin antibody (L-9393, Sigma) or wheat germ 
agglutinin (WGA) conjugated with AlexaFluor 488 or AlexaFluor 647 (Thermo Fisher). Images were 
collected using the epifluorescence microscope Eclipse 800 (Nikon) and analysis of the distribution of 
the different fiber types were performed with the ImageJ software. For the analysis of MCT1 and MCT4 
distribution, anti-MCT1 and anti-MCT4 antibodies previously characterized by our laboratory (Philp et 
al., 2003) were used. For spinal cord histological analysis, samples were collected and fixed overnight 
in 4% paraformaldehyde. After cryopreservation in 30% sucrose solution the samples were frozen in 
Tissue-tek OCT compound and stored at -80. For motoneurons analysis, 25um thick transversal 
sections from the lumbar portion of the spinal cord were cut and stained with 0.5% cresyl violet acetate 
solution and images were captured using cellSens Entry software and the Olympus DP22 camera 
attached to an Olympus CX41 microscope (Olympus Scientific Solutions Americas). Motoneurons were 
identified as larger polygonal cells, with diameter larger than 100μm in the ventral horn. For every 
subject 3 different sections, 150 μm apart were evaluated.  
Exercise tolerance test. 
Exercise tolerance was assessed using a motorized Exer3-6 treadmill system with shock counter 
(Columbus Instruments, Columbus OH). Mice were acclimated to the treadmill for 3 consecutive days 
with a 10 minutes session at 0 incline (1- zero shock, 5m/min speed, 2- 1hz 0.5mA shock, 5m/min 
speed for 5 min, 10m/min speed 5min, 3- 1hz 0.5mA shock, 10m/min speed). Between acclimation and 
test the mice rested for 48h. The test was performed at 5º incline, it started at 10m/min and the speed 
was increased by 2m/min every 3 minutes, until a maximum speed of 26m/min was reached. Maximum 
speed, time on belt and distance run, as well as the number of the shocks received during the test, 
were recorded. The mice were considered exhausted when they sat on the shock grid for 5 consecutive 
seconds despite the shocks.  
Voluntary wheel running test.  
Mice were single housed in cages equipped with wheels (Columbus Instrument) for 7 days. Wheel 
revolutions during the last 60 hours were acquired and analyzed.  
RNA analysis. 
RNA was extracted with TRIzol Reagent (Thermo Fisher) and cDNA synthesis was performed using 
the RNA to cDNA EcoDry™ Premix kit (Clontech). SYBR green qPCR analysis was performed on the 
QuantStudio 5 real time system (Thermo Fisher). Relative expression was calculated using Rplp0 as 
housekeeping. The primers used were:  
Car2: Fw CAGCGAGCAGATGTCTCATTTC, Rev TTCTTTAGCGGCTGAGCTGG,  
Car3: Fw TTAAGACGAAGGGCAAGGAGG, Rev AGGAGCCGTGATAGGTCCAA,  
Car4: Fw GAGCCAGCTATCCACGTTCC, Rev TTCCGGTCTGCTCTGCCTAT,  
NEH1: Fw GCCTCATGAAGATAGGTTTCCA, Rev ACGTCTGATTGCAGGAAGGG,  
MCT1: Fw TGTTAGTCGGAGCCTTCATT, Rev CACTGGTCGTTGCACTGAATA,  
Rplp0: Fw: AGATTCGGGATATGCTGTTGGC, Rev TCGGGTCCTAGACCAGTGTTC. 
Intramuscular lactate measurement. 
After stimulation, muscles were rapidly frozen in liquid nitrogen. 30 to 50 mg of gastrocnemius muscle 
were homogenized in ice cold 0.6M perchloric acid with a handheld homogenizer and then centrifuged 
at 14000 rpm for 15 minutes. The supernatant pH was neutralized with 1.8M potassium carbonate. After 
further centrifugation the supernatants were collected and used for lactate assay using a commercial 
kit (Trinity Biotech).  
Blood Glucose measurement. 
Blood glucose was measured before and right after treadmill test from tail blood using a commercialy 
available glucose meter (Precision Xtra Glucose Meter, Abbot) 
Western Blot analysis. 
Skeletal muscle tissue was homogenized in a buffer containing 50mM Tris, pH8, 150mM NaCl, 5mM 
EDTA, 0.1% SDS, 1% Triton X-100 and 0.5% Deoxycholic acid. Samples were separated in a 4-12% 
Bis-Tris precast Nupage gels (Thermo fisher) and blotted onto PVDF membranes. Membranes were 
blocked in 5% no-fat milk in TBS-tween buffer and incubated overnight with primary antibodies. After 
washing the membranes in TBS-tween buffer they were incubated in HRP conjugated secondary 
antibodies for 1h at room temperature. We developed the blots using SuperSignal West Dura ECL 
substrate (ThermoFisher Scientific) and imaged using FluorChem M ProteinSimple imager.  
CMAP and ex vivo EDL contractility analysis. 
During all ex vivo and in vivo procedures, the genotype of the mice was not disclosed to the operator. 
For the analysis of Compound Muscle Action Potential (CMAP), mice were anesthetized with 1% 
isoflurane. Depth of anesthesia was confirmed by toe pinch and by monitoring heart rate and SpO2 with 
a pulse oximeter (PhysioSuite, Kent Scientific). The sciatic nerve was exposed, crushed distally to the 
muscle to prevent retrograde propagation of the stimuli, and connected to a custom-made bipolar 
stimulating electrode driven by a Grass S48 stimulator. Two recording silver EMG needle-electrodes 
were applied at fixed distance (5 mm), one in the gastrocnemius and the other near the Achilles tendon. 
The ground electrode was connected to the skin of the back of the mouse. The recording electrodes 
were then connected to a Warner Instruments DP-311 differential amplifier, band-pass filtered (0.1-10k 
Hz) and finally fed into a PowerLab/8Sp A/D converter (AD Instruments). One leg of each mouse was 
electrically stimulated, while the other was left unstimulated and used to dissect the EDL muscle for ex 
vivo contractility testing after completion of the CMAP protocol. Three trains of ten stimulating pulses 
(5V, 0.1ms duration) were applied for each frequency tested (1, 3, 5, 10, 20, 40Hz), allowing 2 minutes 
for recovery between each train. Data were acquired and analyzed with LabChart8 (AD Instruments), 
calculating EMG amplitude and root mean square (RMS) of the signal. 
Muscle physiological analysis was performed on isolated EDL muscles using an Aurora Mouse 1200A 
System equipped with Dynamic Muscle Control v.5.415 software. EDL muscles were dissected and 
analyzed in constantly oxygenated Ringer's solution (100mM NaCl, 4.7mM KCl, 3.4mM CaCl2, 1.2mM 
KH2PO4, 1.mM MgSO4, 25mM HEPES, 5.5mM D-glucose) at 24°C. The twitch stimulation protocol 
applied was a single stimulus with a duration of 0.2 ms. Muscle length was adjusted to obtain the 
maximal twitch response and this length was measured and recorded as optimal length (L0). For 
measuring tetanic maximal force generation, the stimulus was repeated at a frequency of 120Hz for 
500ms. Five minutes were allowed between two tetanic contractions to ensure muscle recovery. For 
induction of fatigue, 5 min after the last maximal tetanic contraction, muscles were stimulated every 
second for 8 min using 40-Hz pulses lasting 330 ms. Muscle cross-sectional area (CSA) of EDL muscles 
was calculated by dividing the muscle mass by the product of the muscle density coefficient (1.06 
g/cm3), muscle L0, and the fiber length coefficient (0.45 for EDL). Specific force was determined by 
normalizing maximum isometric tetanic force to CSA. 
In situ hybridization. 
RNAScope technology was used for in situ hybridization following manufacturer’s protocol. Briefly, 
10um thick section were pretreated with hydrogen peroxide and protease. The slides were then 
incubated with RNAScope probe (mmSlc16a3) for 2 h at 40ºC followed by the amplification steps 
according to protocol. Signal was developed using the RNAscope 2.5 HD Manual Detection Kit Red. 
The slides were then blocked in 5% BSA and immunostained with anti GFAP (Sigma) over night. The 
next day donkey anti rabbit AlexaFluor 488 (Thermo Fisher) secondary antibody was applied for 1 hour 
and after washing slides were mounted in ProLong Diamond antifade mounting media with DAPI 
(Thermo Fisher). Images were captured on a Nikon Eclipse E800 with 4x/0.13 and 40x/0.75 DIC 
objectives.  
Sciatic nerve morphological analysis. 
Sciatic nerves were dissected and fixed in 4% glutaraldehyde in 0.1M Millonig buffer for 2 hours, rinsed 
in 0.54% glucose in Millonig buffer overnight and osmicated in 2% OsO4 for 45 minutes. After 
dehydrations the samples were embedded in Durcupan resin. 500nm sections were cut with a glass 
knife using a Leica UCT ultramicrotome, and then stained with 1% Toluidine blue and images were 
captured with Olympus CX41 microscope (Olympus Scientific Solutions Americas). Morphometric 
analysis of the myelinated axons was done with the Halo software, Axon module (IndicaLab, 
Albuquerque NM, USA). Axons and fibers diameter were recorded, and g-ratio was calculated.  
Neuromuscular junction staining. 
EDLs and solei were dissected, cleaned from connective tissue and fixed in 4%PFA and processed for 
immunohistochemistry as previously described (Wright et al., 2007). They were then incubated with 
rhodamine-conjugated alpha-bungarotoxin (Thermo Fisher) to label acetylcholine receptors. After 
permeabilization in methanol, samples were blocked in 2% BSA and then incubated overnight with 
primaries antibodies, SMI-312R (Covance) and SV-2 (Hybridoma bank) for labeling motor axons and 
terminal vesicles, respectively. After washing in PBS, samples were incubated for 1hour with with FITC 
anti-mouse IgG secondary (Jackson ImmunoResearch). Samples were mounted with Vectashield 
mounting media and coverslipped. Samples were then analyzed for total numbers of intact, completely 
denervated, partially denervated and multiply innervated NMJs. Each junction was categorized as 1) 
intact if there was complete overlap between presynaptic nerve terminal and postsynaptic AChRs, 2) 
partially denervated with only partial occupation of postsynaptic AChRs by the overlying nerve terminal, 
or 3) completely denervated, with no occupation of postsynaptic AChRs by the nerve terminal. To 
ensure that a junction was completely denervated, and that the absence of the nerve terminal was not 
an artifact of the staining procedure, junctions were only counted as completely denervated if there 
were other nearby labeled junctions in the same viewing plane. Rapresentative images were captured 
using a Nikon A1R confocal microscope, with a 40X/1.3 oil objective. For analysis of the post synaptic 
endplate density, 25μm thick frozen cross sections of EDLs muscle were stained with rhodamine-
conjugated alpha-bungarotoxin. Z-stack images of en-face NMJs were collected using the Nikon A1R 
confocal microscope and processed with ImageJ to obtain a maximum intensity projection from the Z-
stack. Using the Cell Profiler software the images were batch processed and total area occupied by the 
staining and the perimeter were quantified. Dispersion index was calculated as ratio between the total 
perimeter and total area.  
Statistical analyses. 
Data are represented as mean ± SEM. Data were processed and analyzed with GraphPad Prism 8 
(GraphPad software). Before any statistical analysis was applied, data were assessed for normality 
using the D’Agostino-Pearson’s test. Normally distributed data were compared using the student’s t 
test, for non-normlly distributed data, the Mann-Whitney test was applied. Data in Fig.2A were analyzed 
using a One-Way ANOVA test, followed by Tukey’s test for multiple comparisons. Data in Fig.3E-F and 
4D were analyzed with a 2-way ANOVA test followed by Tukey’s test for multiple comparisons. For 
analysis of NMJs in Fig.7B a Chi-square test was applied. P< 0.05 was considered statistically 
significant. 
REFERENCES:
Wright, M.C., Cho, W.-J., Son, Y.-J., 2007. Distinct patterns of motor nerve terminal sprouting induced 
by ciliary neurotrophic factor vs. botulinum toxin. J. Comp. Neurol. 504, 1–16. 
